Symmetrization Timing in Therapeutic Mammoplasty for Breast Cancer
Overview
Therapeutic mammoplasty combines cancer excision with breast reshaping but often results in asymmetry requiring contralateral symmetrization. Immediate symmetrization is safe, cost-effective, and improves quality of life compared to delayed symmetrization, which can cause prolonged distress and logistical challenges.
Background
Therapeutic mammoplasty involves wide local excision of breast cancer with reshaping of the breast, often leading to asymmetry. Managing this asymmetry is critical as it impacts quality of life in breast cancer survivors. Approaches include immediate symmetrization during the initial surgery or delayed symmetrization after radiation effects stabilize. Traditionally, delayed symmetrization has been favored to allow for radiation-related changes, but this approach has drawbacks including patient distress and increased healthcare resource use.
Data Highlights
Parameter
Value
Increase in therapeutic mammoplasty use (UK, past decade)
400%
Percentage of women noticing asymmetry post breast-conserving surgery
72–100%
Percentage unhappy with immediate outcome
28–32%
Median time to delayed symmetrization (pre-COVID)
14 months (IQR 10)
Cost savings with immediate symmetrization
€5500 (range €4330–€6570)
Audience opinion split on timing of symmetrization
51% immediate vs 49% delayed
Key Findings
Immediate symmetrization during therapeutic mammoplasty is safe with no increase in complications or delays to adjuvant therapy.
Delayed symmetrization leads to prolonged patient distress, embarrassment, and reduced quality of life due to noticeable asymmetry.
Immediate symmetrization offers significant cost savings compared to delayed procedures.
A dual-consultant, two-team surgical model facilitates immediate symmetrization and training without compromising outcomes.
There is a lack of prospective comparative data on patient-reported outcomes and cost-effectiveness between immediate and delayed symmetrization.
Breast surgeons remain divided on the optimal timing, highlighting the need for further research and consensus building.
Clinical Implications
Clinicians should consider immediate symmetrization as a viable and potentially preferable option for managing asymmetry after therapeutic mammoplasty, given its safety profile and benefits in patient quality of life and healthcare resource utilization. Adoption of dual-consultant surgical models may optimize outcomes and training. Further prospective studies are needed to guide individualized patient-centered decision-making.
Conclusion
Immediate symmetrization in therapeutic mammoplasty appears to offer advantages in safety, cost, and patient quality of life, but definitive guidance awaits robust comparative data. Collaborative efforts are required to establish best practices and optimize care pathways.
References
Authors/Editorial/2024 -- Symmetrization Techniques in Therapeutic Mammoplasty for Breast Cancer Management
